2023 annual financial data
SpyGlass Pharma 2023 Operating margin
SpyGlass Pharma 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -14,230,365 USD and net income was -13,318,990 USD.
Operating cash flow was -12,277,733 USD.
Get free SpyGlass Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -14,230,365 USD
- Net income
- -13,318,990 USD
- Operating cash flow
- -12,277,733 USD